Skip to Page Content

The Review Course for the ABOM Exam addresses clinical topics physicians need to know for the American Board of Obesity Medicine (ABOM) certifciation exam. If you're a physician planning to take the exam, use this opportunity to sutdy for the exam. 

 

The presentations within 2016 Review Course for the ABOM Exam can be purchased together as a series, or individually by session:

 

  • To purchase the entire series, click the Add to Cart button located directly below the pricing, and proceed to checkout.
     
  • To purchase sessions within the series, click the Purchase Individual Sessions¯ option, and select the check boxes below the session(s) you would like to purchase. Once sessions are selected, an additional Add to Cart button will appear below the number of sessions selected, to the right of your screen, as well as at the bottom of the page. Click the Add to Cart¯ button and
  • proceed to checkout.

 

Accreditation: 
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

The OMA designates this enduring material internet activity for a maximum of 12.50 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Presentation Information
Presentation Date:
September 21, 2016
Expiration Date:
August 15, 2019 11:55 PM
Presentation Objectives
  • Understand the treatment of obesity and the genetic, biologic, environmental, social, and behavioral factors that contribute to obesity.
  • Employ therapeutic interventions including diet, physical activity, behavior change, and pharmacotherapy.
  • Interact more confidently with patients in regards to their individual weight and health issues associated with obesity.
  • Understand obesity as a disease state.
  • Prepare learners to pass the certification examination for obesity medicine physicians.
  • Maintain competence in providing pre-, peri-, and post-surgical care of bariatric surgery patients.
  • Promote the prevention of obesity, and advocate for those patients who suffer from obesity.
  • Prescribe a comprehensive and individualized approach to achieve optimal results for each patient (adult, adolescent, and/or child) affected by obesity.
Epidemiology and Determinants of Obesity
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Articolo defines obesity and discusses the genetic, environmental, and cultural factors associated with obesity.
 


Disclosures (at time of recording):
Speaker:

  • Amy Arrow Articolo, DO, FACOOG, Dipl. ABOM
    • Novo Nordisk, Speakers Bureau, Advisory Activities, Development of Educational Activities

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Define obesity
  • Review the incidence and prevalence of obesity
  • Review the genetic, environmental, and cultural factors of obesity
  • Understand the financial costs of obesity, the pathophysiology of obesity-related disorders and the psychosocial aspects of obesity

Originally Recorded: 9/21/2016

Speaker Information
Amy Articolo  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$15.00
Non Member Price: Become a Member!   $20.00
Assessment and Evaluation
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Ferguson discusses how to assemble an obesity-related physical along with selecting appropriate tests including lab, radiology, and other assessments.
 


Disclosures (at time of recording):
Speaker:

  • Ursula Inge Ferguson, DO, FACOI, FOMA, Dipl. ABOM: Nothing to disclose

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Pass the Certification Examination of Obesity Medicine Physicians
  • Assemble a complete obesity-related history and physical
  • Select appropriate tests: lab, radiology, and other assessments
  • Beware of questionnaire and guideline resources

Originally Recorded: 9/21/2016

Speaker Information
Ursula Inge Ferguson  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$15.00
Non Member Price: Become a Member!   $20.00
Obesity Medicine Treatment Strategies
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Hallberg discusses different treatment strategies along with managing weight plateaus and co-morbid conditions.

 


Disclosures (at time of recording):
Speaker:

  • Sarah Hallberg, DO, MS, Dipl. ABOM
    • Arkins Corporation: Advisory Activities

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Age-related treatment
  • Prevention of obesity and weight gain
  • Risks associated with excessive weight loss
  • Management of a weight plateau
  • Management of co-morbid conditions during weight loss
  • Effect of weight loss on co-morbid conditions

Originally Recorded: 9/21/2016

Speaker Information
Sarah Hallberg  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$15.00
Non Member Price: Become a Member!   $20.00
Practice Management
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Articolo addresses the issues and office policies and protocols related to treating a patient affected with obesity.

 


Disclosures (at time of recording):
Speaker: 

  • Amy Arrow Articolo, DO, FACOOG, Dipl. ABOM
    • Novo Nordisk: Speakers Bureau, Advisory Activities
    • Development of Educational Activities

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Recognition of weight bias, stigma, and discrimination
  • Recognizing and addressing the issues and office policies and protocols related to treating the patient affected by obesity
  • Recognition of the current guidelines and algorithms for adult obesity medicine treatment

Originally Recorded: 9/21/2016

Speaker Information
Amy Arrow Articolo  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$10.00
Non Member Price: Become a Member!   $13.00
Physical Activity
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Horn reviews the basics of creating an indvidualized exercise prescription along with the role physical activity has in weight loss.

 


Disclosures (at time of recording):
Speaker:

  • Deborah Bade Horn, DO, MPH, MFOMA, Dipl. ABOM
    • Novo Nordisk, Inc: Speakers Buraeu, Honoraria, and Advisory Activties
    • Orexigen Therapeutics, Inc: Speakers Bureau, Honorario, and Advisory Activities

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Distinguish differences between physical activity, exercise, and non-exercise activity thermogenesis
  • Review muscle anatomy and exercise physiology
  • Review current evidence involving physical activity and its role in weight loss, weight maintenance, and reduction in all cause mortality
  • Review the components of an exercise history, basics of creating an individualized exercise prescription, and risks involved with exercise

Originally Recorded: 9/21/2016

Speaker Information
Deborah Bade Horn  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$20.00
Non Member Price: Become a Member!   $26.00
Nutrition (Part 1)
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Lazarus discusses macro and micronutrients and their Dietary Reference Intakes (DRI) along with meal replacements and low-calorie diets.

 


Disclosures (at time of recording):
Speaker:

  • Ethan Lazarus, MD, Dipl. ABOM
    • Novo Nordisk, Inc: Speakers Bureau, Advisory Activties
    • Orexigen Therapeutics, Inc: Speakers Bureau
    • Eisai, Inc: Speakers Bureau

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Nutrition:
    • Dietary Reference Intakes (DRI) for macro and micronutrients
    • GI sites of nutrient absorption
    • Obesity-related vitamin and mineral metabolism (Ca, PTH, B12, Vit. D)
    • Macronutrient diet composition and effects on body weight and metabolism
  • Diet:
    • Calorie and micro/macro nutrient
    • Very low-calorie diet
    • Meal replacement
    • Available resources 
    • Co-morbid conditions

Originally Recorded: 9/21/2016

 

Speaker Information
Ethan Lazarus  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$15.00
Non Member Price: Become a Member!   $20.00
Q&A Panel
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: The panel addresses questions regarding assessment and evaluation, physical activity, and nutrition.
 


Disclosures (at time of recording):
Speakers:

  • Ursula Inge Ferguson, DO, FACOI, FOMA, Dipl. ABOM: Nothing to disclose
  • Deborah Bade Horn, DO, MPH, MFOMA, Dipl. ABOM
    • Novo Nordisk: Speakers Bureau, Honoraria, and Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Ethan Lazarus, MD, Dipl. ABOM
    •  Novo Nordisk: Speakers Bureau and Advisory Activities; Orexigen Therapeutics, Inc: Speakers Bureau; Eisai, Inc.: Speakers Bureau

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Originally Recorded: 9/21/2016

Speaker Information
Ursula Inge Ferguson  [ view bio ]
Deborah Bade Horn  [ view bio ]
Ethan Lazarus  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$5.00
Non Member Price: Become a Member!   $7.00
Behavioral and Psychosocial Diagnosis and Treatment
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Knopke reviews common behavioral problems related to obesity and treatment plans to address these behaviors. 

 


Disclosures (at time of recording):
Speaker:

  • Carl Knopke, MD, Dipl. ABOM
    • Novo Nordisk, Inc: Advisory Activities

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Review obesity-related neruological principles
  • Review common obesity-related behavioral problems
  • Eating disorders
  • Body image disorders
  • Mood, anxiety, personality disorders
  • Sleep disorders
  • Review treatments for specific behavioral problems
  • Psychological therapies
  • Pharmacologic therapies

Originally Recorded: 9/22/2016

Speaker Information
Carl Knopke  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$20.00
Non Member Price: Become a Member!   $26.00
Surgery
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Clark discusses types of weight-loss surgery (WLS) procedures along with the risks and benefits assoicated with these procedures.

 


Disclosures (at time of recording):
Speaker:

  • Thomas W. Clark, MD, MS, FACS, FASMBS, Dipl. ABOM: Nothing to disclose

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Types, risks, and benefits of the different weight-loss surgery (WLS) procedures
  • Pre-operative medical assessment and preparation
  • Complications
  • Post-op medical management
  • Nutritional management
  • Adolescent surgery
  • WLS/pregnancy

Originally Recorded: 9/22/2016

Speaker Information
Thomas Clark  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$25.00
Non Member Price: Become a Member!   $33.00
Nutrition (Part 2)
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Lazarus discusses macro and micronutrients and their Dietary Reference Intakes (DRI) along with meal replacements and low-calorie diets.

 


Disclosures (at time of recording):
Speaker:

  • Ethan Lazarus, MD, Dipl. ABOM
    • Novo Nordisk, Inc: Speakers Bureau, Advisory Activties
    • Orexigen Therapeutics, Inc: Speakers Bureau
    • Eisai, Inc: Speakers Bureau

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Nutrition:
    • Dietary Reference Intakes (DRI) for macro and micronutrients
    • GI sites of nutrient absorption
    • Obesity-related vitamin and mineral metabolism (Ca, PTH, B12, Vit. D)
    • Macronutrient diet composition and effects on body weight and metabolism
  • Diet:
    • Calorie and micro/macro nutrient
    • Very low-calorie diet
    • Meal replacement
    • Available resources 
    • Co-morbid conditions

Originally Recorded: 9/21/2016

Speaker Information
Ethan Lazarus  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$15.00
Non Member Price: Become a Member!   $20.00
Pathophysiology (Part 1)
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description:  Dr. Sicat reviews peripheral and CNS hormones along with the functions of different types of body fat and the impact of their distribution.

 


Disclosures (at time of recording):
Speaker:

  • Jeffrey Sicat, MD, FACE, Dipl. ABOM
    • Orexigen Therapeutics, Inc: Speakers Bureau, Advisory Activities
    • Novo Nordisk, Inc: Speakers Bureau, Advisory Activties
    • Eisai, Inc: Speakers Bureau

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Understand the complexity of weight control at the CNS level
  • Review the peripheral hormones that assist with weight regulation
  • Review the CNS hormones that control energy balance
  • Follow the path of signaling from the hypothalamus, 1st and 2nd order neurons
  • Discuss the function of orexigens and anorexigens at the CNS level
  • Discuss genetic obesity disorders and their relationship to hormones
  • Understand the emerging science on the intestinal microbiome and its effect on weight regulation
  • Discuss the impact of disordered sleep on metabolic parameters
  • Review the functions of different types of body fat and the impact of their distribution
  • Discuss obesity-related co-morbidities

Originally Recorded: 9/22/2016

Speaker Information
Jeffrey Sicat  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$25.00
Non Member Price: Become a Member!   $33.00
Pathophysiology (Part 2)
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description:  Dr. Sicat reviews peripheral and CNS hormones along with the functions of different types of body fat and the impact of their distribution.

 


Disclosures (at time of recording):
Speaker:

  • Jeffrey Sicat, MD, FACE, Dipl. ABOM
    • Orexigen Therapeutics, Inc: Speakers Bureau, Advisory Activities
    • Novo Nordisk, Inc: Speakers Bureau, Advisory Activties
    • Eisai, Inc: Speakers Bureau

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Understand the complexity of weight control at the CNS level
  • Review the peripheral hormones that assist with weight regulation
  • Review the CNS hormones that control energy balance
  • Follow the path of signaling from the hypothalamus, 1st and 2nd order neurons
  • Discuss the function of orexigens and anorexigens at the CNS level
  • Discuss genetic obesity disorders and their relationship to hormones
  • Understand the emerging science on the intestinal microbiome and its effect on weight regulation
  • Discuss the impact of disordered sleep on metabolic parameters
  • Review the functions of different types of body fat and the impact of their distribution
  • Discuss obesity-related co-morbidities

Originally Recorded: 9/22/2016

Speaker Information
Jeffrey Sicat  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$25.00
Non Member Price: Become a Member!   $33.00
Pharmacotherapy
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: Dr. Butsch discusses current FDA-approved and off-label anti-obesity medications along with their efficacy, indications, contraindications, and safety.

 


Disclosures (at time of recording):
Speaker:

  • W. Scott Butsch, MD, MSc, Dipl. ABOM: Nothing to disclose

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Historical view of anti-obesity agents
  • Current anti-obesity medications:
  • FDA-approved, off-label, dietary supplements
  • Efficacy, indications, contraindications, safety
  • Prescribing protocols, REMS
  • Combination therapy
  • Weight gain promoting medications

Originally Recorded: 9/22/2016

Speaker Information
Scott Butsch  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$20.00
Non Member Price: Become a Member!   $26.00
Pediatrics
CME/CE Expiration Date: 09/15/2019*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description:  In Pediatrics (Parts 1 and 2), Dr. Cuda will review the epidemiology and risk factors for childhood obesity including environmental influences, 2007 Expert Committee Recommendations and flow charts in detail, as well as how to evaluate and treat children affected by obesity.

 

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Disclosures (at time of recording):
Speaker:

  • Suzanne Cuda, MD, FAAP, Dipl. ABOM: Nothing to disclose

Planners:

  • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
  • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
  • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
  • Michael Bateman, DO: Mead Johnson: Speakers Bureau
  • Erin Chamberlin, MD, FAAFP: Orexigen Therapeutics, Inc.: Speakers Bureau
  • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
  • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
  • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
  • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

Objectives:

  • Brief review of epidemiology and risk factors for childhood obesity including environmental influences
  • Review 2007 Expert Committee Recommendations and flow charts in detail
  • Discuss evaluation and treatment of a child affected by obesity

Originally Recorded: 9/22/2016

Speaker Information
Suzanne Cuda  [ view bio ]
ProductAddPrice
Streaming + MP4 Download
OMA Member Price:
$25.00
Non Member Price: Become a Member!   $33.00
Individual topic purchase: Selected
Obesity Medicine Association
AMA PRA Category 1 Credit(s)ā„¢: 12.50
Participation Credit(s): 12.50
Share This
Preview
Preview Epidemiology and Determinants of ObesityPreview Epidemiology and Determinants of Obesity
Subscription
You must be logged in to access OMA Subscriptions.
To continue, you need to log in to oma. If you have any questions about your account please contact us at 1-866-702-3278.
Email Address:
Password:
Products
On-demand
OMA Member Price:
$225.00
Non Member Price: Become a Member!   $293.00